Brief: Schott Pharma AG & Co. KGaA See FY 25 Impacted By Slower Growth From Syringes

SCHOTT Pharma AG & Co KgaA

14/05/2024 17:08

May 14 (Reuters) - SCHOTT Pharma AG & Co KgaA  1SXP.DE :
    * EQS-ADHOC: SCHOTT PHARMA AG & CO. KGAA: SCHOTT PHARMA SEE
FY 25
IMPACTED BY SLOWER GROWTH FROM SYRINGES
    * COMPANY ALSO CONFIRMS ITS FORECAST FOR CURRENT FISCAL
YEAR.
    * CONFIRMS ITS MID-TERM FORECAST
    * FOR FISCAL YEAR 2024/2025 EBITDA MARGIN EXPANSION WILL BE
WEAKER
THAN CURRENTLY EXPECTED IN MARKET

Source text for Eikon:  ID:nEQ1QddBxa 
Further company coverage:  1SXP.DE 

 ((Reuters.Briefs@thomsonreuters.com;))